{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:52:19Z","timestamp":1793371939890,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejmech.2023.115830","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T17:45:54Z","timestamp":1695577554000},"page":"115830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Kinetic modelling of the P-glycoprotein mediated efflux with a large-scale matched molecular pair analysis"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9318-1052","authenticated-orcid":false,"given":"Hongtao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115830_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115830_bib2","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115830_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI1269","article-title":"The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115830_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115830_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood-brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115830_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"Vahakangas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115830_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/pr.55.3.1","article-title":"Impact of drug transporter studies on drug discovery and development","volume":"55","author":"Mizuno","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2023.115830_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115830_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2174\/138920011798357006","article-title":"P-glycoprotein inhibition: the past, the present and the future","volume":"12","author":"Darby","year":"2011","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2023.115830_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115830_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2023.115830_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115830_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","article-title":"The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research","volume":"580","author":"Gottesman","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2023.115830_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115830_bib15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115830_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115830_bib17","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1073\/pnas.2010264117","article-title":"Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1","volume":"117","author":"Nosol","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115830_bib18","doi-asserted-by":"crossref","first-page":"E1973","DOI":"10.1073\/pnas.1717044115","article-title":"Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1","volume":"115","author":"Alam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115830_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1126\/science.aar7389","article-title":"Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation","volume":"359","author":"Kim","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115830_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2003.12.004","article-title":"The factors that influence permeation across the blood-brain barrier","volume":"39","author":"Abraham","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.2042-7158.1997.tb06072.x","article-title":"Molecular factors influencing drug transfer across the blood-brain barrier","volume":"49","author":"Gratton","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115830_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/10611869808997889","article-title":"Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors","volume":"6","author":"van de Waterbeemd","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejmech.2023.115830_bib23","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure-brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib24","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/jm201136z","article-title":"Structural modifications that alter the P-glycoprotein efflux properties of compounds","volume":"55","author":"Hitchcock","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3187","article-title":"Coexistence of passive and carrier-mediated processes in drug transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115830_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/cn3001922","article-title":"Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein","volume":"4","author":"Dolghih","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115830_bib27","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/acs.jcim.0c00525","article-title":"Combining machine learning and molecular dynamics to predict P-glycoprotein substrates","volume":"60","author":"Esposito","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115830_bib28","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/febs.12773","article-title":"The central cavity of ABCB1 undergoes alternating access during ATP hydrolysis","volume":"281","author":"van Wonderen","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2023.115830_bib29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1021\/acs.molpharmaceut.6b01059","article-title":"In vitro intrinsic permeability: a transporter-independent measure of Caco-2 cell permeability in drug design and development","volume":"14","author":"Fredlund","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2023.115830_bib30","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/jps.23194","article-title":"Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry","volume":"101","author":"Cai","year":"2012","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115830_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/adt.2020.970","article-title":"A fully integrated assay panel for early drug metabolism and pharmacokinetics profiling","volume":"18","author":"Wernevik","year":"2020","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2023.115830_bib32","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/ci900450m","article-title":"Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets","volume":"50","author":"Hussain","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115830_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115830_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/acs.jmedchem.2c01577","article-title":"Trends in molecular properties, bioavailability, and permeability across the Bayer compound collection","volume":"66","author":"Dh","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ci000403i","article-title":"Molecular complexity and its impact on the probability of finding leads for drug discovery","volume":"41","author":"Hann","year":"2001","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2023.115830_bib38","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/S0021-9258(19)39690-5","article-title":"Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells","volume":"265","author":"Raviv","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib39","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U","article-title":"The hydrogen bond in the solid state","volume":"41","author":"Steiner","year":"2002","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2023.115830_bib41","doi-asserted-by":"crossref","first-page":"18903","DOI":"10.1021\/ja207494u","article-title":"Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design","volume":"133","author":"Schmidtke","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115830_bib42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1039\/D0MD00178C","article-title":"A structure-kinetic relationship study using matched molecular pair analysis","volume":"11","author":"Schuetz","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acschembio.9b00092","article-title":"SPR-Measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate","volume":"14","author":"Roy","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115830_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41467-018-08027-7","article-title":"Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase","volume":"10","author":"Smith","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115830_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/bmb.2006.494034062678","article-title":"Time, the forgotten dimension of ligand binding teaching","volume":"34","author":"Corzo","year":"2006","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.ejmech.2023.115830_bib46","doi-asserted-by":"crossref","first-page":"13524","DOI":"10.1021\/acs.jmedchem.1c00920","article-title":"Optimization of an imidazo[1,2-a]pyridine series to afford highly selective type I1\/2 dual Mer\/Axl kinase inhibitors with in vivo efficacy","volume":"64","author":"McCoull","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib47","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1016\/j.bmcl.2016.08.030","article-title":"Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering","volume":"26","author":"Gu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115830_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/acs.jcim.6b00005","article-title":"Simple predictive models of passive membrane permeability incorporating size-dependent membrane-water partition","volume":"56","author":"Leung","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115830_bib49","doi-asserted-by":"crossref","first-page":"14261","DOI":"10.1021\/acs.jmedchem.2c01147","article-title":"Hydrogen-bond donors in drug design","volume":"65","author":"Kenny","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115830_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008130001697","article-title":"Property distribution of drug-related chemical databases","volume":"14","author":"Oprea","year":"2000","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423007973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423007973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:58:29Z","timestamp":1759330709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423007973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S0223523423007973"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115830","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetic modelling of the P-glycoprotein mediated efflux with a large-scale matched molecular pair analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115830"}}